BrosMed Enters 10th Anniversary Year
Release time:
2022-03-01
BrosMed Medical Co., Ltd.(“BrosMed”) is celebrating its 10-year anniversary today!
BrosMed Medical Co., Ltd.(“BrosMed”) is celebrating its 10-year anniversary today!
BrosMed was established on March 1st, 2012. In the past 10 years, a group of excellent domestic and foreign industry elites joined together. BrosMed has become a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices and accessories.
At present, BrosMed have four R&D centers (Labs) and three manufacturing sites in China, Europe and Asian Pacific. “Inventing a movement, improving lives and inspiring everyone.” BrosMed products have been distributed to thousands of hospitals in more than 60 countries and regions.
With over 30 product series, and over 150 product registration certificates worldwide, BrosMed global product covers the fields of cardiovascular interventions, peripheral vascular interventions and a full set of interventional accessories. It is particularly worth mentioning that BrosMed products were highly praised for its excellent performance and superior quality around the world.
BrosMed remains committed to providing innovative devices to our physician and their patients and we will strive to continue to develop and introduce devices that address common clinical challenges with existing products.
To our clients, candidates and team members – thank you for coming on this journey with us. Your support makes BrosMed what it is today.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
